Iovance Biotherapeutics(IOVA) - 2024 Q1 - Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Results Conference Call May 9, 2024 4:30 PM ET Company Participants Sara Pellegrino - Senior Vice President, Investor Relations & Corporate Communications Dr. Fred Vogt - Interim President & Chief Executive Officer Jim Ziegler - Executive Vice President, Commercial Dr. Igor Bilinsky - Chief Operating Officer Jean-Marc Bellemin - Chief Financial Officer Dr. Friedrich Finckenstein - Chief Medical Officer Dr. Brian Gastman - Executive Vice President, Medical ...